|
|
|
|
|
by stultissimus
894 days ago
|
|
Synthetic biologist here. This is a good answer, but looking at man-made genetic programs can give us a simplified perspective. We've made significant progress engineering programs that enable human T cells to kill target (cancer) cells _conditionally_ based on their surface marker expression [1]. This is in contrast to conventional CAR-T cells which are already on the market (see Kymriah, etc.). A simple AND gate T cell circuit is currently being tested in humans [2]. Numerous strategies now exist to write cellular decision making programs using synthetic circuits. We are entering an era where we can write DNA programs and put them into people; I wonder how we can interest more CS-minded people in this kind of "synthetic biology as programming", especially as we move from proof of concept studies in bacteria to real trials in humans [2]. [1]: https://pubmed.ncbi.nlm.nih.gov/33243890/
[2]: https://arsenalbio.com/2023/05/16/arsenalbio-announces-prese... |
|